Page last updated: 2024-08-26

2,8-dihydroxyadenine and Disease Exacerbation

2,8-dihydroxyadenine has been researched along with Disease Exacerbation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agustsdottir, IM; Edvardsson, VO; Indridason, OS; Palsson, R; Runolfsdottir, HL1
Bensman, A; Bollée, G; Ceballos-Picot, I; Daudon, M; Harambat, J; Knebelmann, B1

Reviews

1 review(s) available for 2,8-dihydroxyadenine and Disease Exacerbation

ArticleYear
Adenine phosphoribosyltransferase deficiency.
    Clinical journal of the American Society of Nephrology : CJASN, 2012, Volume: 7, Issue:9

    Topics: Adenine; Adenine Phosphoribosyltransferase; Allopurinol; Animals; Biomarkers; Disease Progression; Enzyme Inhibitors; Genetic Predisposition to Disease; Humans; Kidney Diseases; Metabolism, Inborn Errors; Phenotype; Predictive Value of Tests; Prognosis; Recurrence; Urolithiasis; Xanthine Dehydrogenase

2012

Other Studies

1 other study(ies) available for 2,8-dihydroxyadenine and Disease Exacerbation

ArticleYear
Long-term renal outcomes of APRT deficiency presenting in childhood.
    Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:3

    Topics: Acute Kidney Injury; Adenine; Adenine Phosphoribosyltransferase; Adolescent; Adult; Allopurinol; Child; Child, Preschool; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Infant; Kidney; Kidney Calculi; Male; Metabolism, Inborn Errors; Recurrence; Registries; Renal Insufficiency, Chronic; Urolithiasis; Xanthine Dehydrogenase; Young Adult

2019